MEDICAL DEVICE INNOVATION - Medical Device Daily
MEDICAL DEVICE INNOVATION - Medical Device Daily
MEDICAL DEVICE INNOVATION - Medical Device Daily
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
122<br />
Shape-HF offers easier testing<br />
method for CRT therapy patients<br />
By OMAR FORD<br />
<strong>Medical</strong> <strong>Device</strong> <strong>Daily</strong> Staff Writer<br />
Shape <strong>Medical</strong> Systems (St. Paul, Minnesota) is offering<br />
a much simpler and less intensive way of testing for<br />
measuring ventilation parameters for patients who have<br />
suffered from cardio-illness.<br />
The Shape HF Cardiopulmonary Testing System was<br />
given FDA approval at the end of March and objectively<br />
measures CRT response in real time while the patient is<br />
exercising, according to Shape <strong>Medical</strong>. Objectivity is the<br />
key selling point of the device.<br />
“Typically patients are given questionnaires or surveys<br />
– more subjective means to test for CRT responses,”<br />
Clarence Johnson, president/COO of Shape <strong>Medical</strong> told<br />
<strong>Medical</strong> <strong>Device</strong> <strong>Daily</strong>.<br />
Here’s how the device works. As the patient exercises<br />
at a steady state heart rate, the physician adjusts therapy<br />
settings every two minutes, enough time for the adjustments<br />
to be reflected in breathing physiology. At the end of<br />
the test, during which four to five therapy settings are tested,<br />
the Shape-HF System uses a proprietary computer algorithm<br />
to rank the physiological response to exercise at<br />
each setting. The physician then reviews the results and<br />
chooses the therapy setting he or she believes is most<br />
appropriate for the patient. The exercise includes walking<br />
on a treadmill at a very low intensity of one mile per hour<br />
with the treadmill set at a 2% grade.<br />
“Other methods have proven to be very difficult for<br />
patients,” Johnson said. “The Gas inhalation test for example<br />
is very difficult and has often found to bring patients to<br />
the point of exhaustion.”<br />
CRT is a widely used method for treating patients with<br />
severe heart failure when alternative treatment options<br />
have been exhausted. According to Dr. Abraham Kocheril,<br />
professor of medicine and director of Clinical<br />
Electrophysiology at the University of Illinois at Chicago<br />
where the Shape-HF System has already been installed,<br />
“The CRT response rate in heart failure patients is about<br />
70%. The Shape-HF System is likely to help us get the<br />
remaining 30%—those we call non-responders—feeling<br />
better.”<br />
Johnson added that because patient breathing efficiency<br />
is so sensitive to changes in CRT settings, using gas<br />
exchange parameters to assess these changes provides a<br />
completely objective method for defining response to CRT<br />
therapy. Plans call for the company to try and get approval<br />
in Europe.<br />
“We don’t have CE mark yet. This is a device that will<br />
have a wide appeal in Europe,” Johnson said “But we<br />
thought we would go after the domestic market first.” The<br />
company stressed that the Shape-HF System is the only<br />
<strong>MEDICAL</strong> <strong>DEVICE</strong> <strong>INNOVATION</strong> 2010<br />
device that objectively measures CRT response in real time<br />
while the patient is exercising. The system is cost effective,<br />
easy to use, and the test is easy on the patient. “It’s very<br />
easy to use and training for the system can be done in 30<br />
minutes to an hour,” Johnson told MDD. “All of the muss and<br />
the fuss are taken out of the process.”<br />
To date this is the only product the five-year-old company<br />
has released.<br />
CRT is used in severe cases of heart failure to restore<br />
synchrony between the heart chambers—the atria and two<br />
ventricles—during the heartbeat. In patients with advanced<br />
heart failure the heart may not beat strongly enough to<br />
supply adequate oxygen to peripheral tissues, and poor<br />
blood flow to the lungs disrupts the process of exchanging<br />
needed oxygen for carbon dioxide, a waste product of normal<br />
metabolism.<br />
Combined, these effects lower the amount of oxygen in<br />
the blood, which decreases the patient’s ability to exercise<br />
and causes inefficient, labored breathing. Typically shortness<br />
of breath on even mild exertion is a key symptom in<br />
heart failure during CRT therapy. The company said that a<br />
positive response to CRT therapy improves breathing efficiency<br />
during exercise, and that it makes sense that parameters<br />
that can measure patient breathing efficiency, can be<br />
used to determine the proper CRT settings.<br />
(This story originally appeared in the June 2, 2009 edition<br />
of <strong>Medical</strong> <strong>Device</strong> <strong>Daily</strong>.)<br />
To subscribe, please call <strong>MEDICAL</strong> <strong>DEVICE</strong> DAILY Customer Service at (800) 888-3912; outside the U.S. and Canada, call (404) 262-5547.<br />
Copyright © 2010 AHC Media LLC. Reproduction is strictly prohibited.